These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Step-up versus top-down: application of new biological agents in pediatric inflammatory bowel disease. Faubion WA Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1094-6. PubMed ID: 16901767 [No Abstract] [Full Text] [Related]
5. [Systemic corticosteroids in inflammatory bowel disease: are they really effective. What is their real toxicity?]. Bastida G; Muñoz F Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():3-9. PubMed ID: 19087857 [No Abstract] [Full Text] [Related]
9. [Emergency drug therapy of non-specific inflammatory bowel diseases--progress on diagnosis and therapy]. Aasakura H; Honma T; Sugimura K Nihon Naika Gakkai Zasshi; 1995 Nov; 84(11):1815-20. PubMed ID: 8568379 [No Abstract] [Full Text] [Related]
10. [Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?]. Nos Mateu P Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():16-21. PubMed ID: 19087859 [No Abstract] [Full Text] [Related]
11. [Dynamics of serum IL-17A, IL-17F and IL-23 in patients with inflammatory bowel disease]. Lazebnik LB; Sagynbaeva VÉ; Kniazev OV; Ruchkina IN; Efremov LI Eksp Klin Gastroenterol; 2011; (11):49-52. PubMed ID: 22629719 [TBL] [Abstract][Full Text] [Related]
12. General principles of medical therapy of inflammatory bowel disease. Friedman S Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534 [TBL] [Abstract][Full Text] [Related]
15. [New prospects in the treatment of inflammatory bowel disease]. Hinojosa del Val J Gastroenterol Hepatol; 1997; 20(7):370-82. PubMed ID: 9377238 [No Abstract] [Full Text] [Related]
16. [Advances in the use of non-biologic agents in the treatment of inflammatory bowel diseases]. Bosques Padilla F Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():86-90. PubMed ID: 17037785 [No Abstract] [Full Text] [Related]
17. Methotrexate in inflammatory bowel disease. Feagan BG; Alfadhli A Gastroenterol Clin North Am; 2004 Jun; 33(2):407-20, xi. PubMed ID: 15177546 [TBL] [Abstract][Full Text] [Related]
18. [Conventional and immunomodulatory therapy in chronic inflammatory bowel diseases]. Marth T; Zeitz M Dtsch Med Wochenschr; 1999 Oct; 124(40):1173-7. PubMed ID: 10548948 [No Abstract] [Full Text] [Related]
19. Safety and efficacy of cyclosporine therapy in inflammatory bowel disease. Cullen G; Keegan D; O'Donoghue D Am J Gastroenterol; 2008 Oct; 103(10):2654-5; author reply 2655. PubMed ID: 18855861 [No Abstract] [Full Text] [Related]
20. The state of the art in the management of inflammatory bowel disease. Hanauer SB; Present DH Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]